AGER and cancer: Even though RAGE inhibitors could represent a potential strategy for treating certain types of cancer and are available in clinical practice, no specific trials have evaluated the safety and efficacy of RAGE inhibitors in cancer patients either as monotherapy or in combination with chemotherapy and/or other targeted therapies to date.